fibrosis

Launched in March 2020 in response to the coronavirus disease 2019 (COVID-19) pandemic, COVID-Net is a global open source, open access initiative dedicated to accelerating advancement in machine learning to aid front-line healthcare workers and clinical institutions around the world fighting the continuing pandemic. Towards this goal, our global…

Flexible and accessible Python framework for cardiac electrophysiology simulations using finite-difference methods.

A python package to analyze the matrix fiber orientation and intensity around cells in fiber matrices (as a proxy for cellular forces).

In this competition, we’ll predict a patient’s severity of decline in lung function based on a CT scan of their lungs. We’ll determine lung function based on output from a spirometer, which measures the volume of air inhaled and exhaled.

Segmentation of histological images and fibrosis identification with a convolutional neural network

Deep Learning model for predicting Pulmonar Fibrosis evolution

Computational pathology pipeline for tissue fibrosis quantification from whole-slide images using foundation model embeddings

RNA-seq analysis of fibrosis and inflammation signatures in focal segmental glomerulosclerosis (FSGS)

65Roses®🌹 Cure Cystic Fibrosis [65ROSES] BSC SOLANA ETH / Fundraising Token $65Roses 🌹

Repository with the analysis of two kidney fibrosis models in mouse

Open-source Python package to assist researchers in cardiac modeling by providing tools for generating and analyzing realistic cardiac fibrosis textures.

Code for proceeding paper in FIMH2019

Analysis of a CD45-enriched scRNAseq dataset from 6 weeks after volumetric muscle loss with synthetic material implant.

Understanding the effect of BAFF signalling in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Projects and study notes related to bio and brain engineering.

Bulk RNAseq analysis of stromal cells from peri-implant fibrosis of mice with and without ETBF infection

Analysis of γδ T cell phenotype and communication in peri-implant fibrosis

Agomab Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Agomab Therapeutics is a clinical-stage biopharmaceutical company (Nasdaq: AGMB) developing novel disease-modifying therapies for fibro-inflammatory diseases, with an initial focus on chronic fibrotic indications of high unmet medical need such as Croh

Arresto Biosciences — independent third-party profile of a public API surface, by API Evangelist. Arresto Biosciences, Inc. was a privately-held, development-stage biotechnology company headquartered in Palo Alto, California, focused on medicines to treat fibrotic diseases and cancer by targeting enzymes involved in the synthesis of the extracellul